CONFIDENTIALITY ARRANGEMENT BETWEEN EU AND BRAZILIAN REGULATORY AUTHORITIES
The European Medicines Agency (EMA) and the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) signed a confidentiality…
READ
ADVERTISING OF MEDICINES TO HEALTHCARE PROFESSIONALS AND TO GENERAL PUBLIC IN ITALY
According to the Legislative Decree 219/06, it is possible to develop promotional material for Healthcare Professionals (HCPs) and for general…
READ
ONCOLOGY NETWORKS ACTIVE IN 17 REGIONS IN ITALY
At the end of 2020, 20/21 Italian Regions, activated a Cancer Registry and 17/21 formalized a governing body of the…
READ
REIMBURSED EARLY ACCESS TO UNAUTHORISED MEDICINAL PRODUCTS OR THERAPEUTIC INDICATIONS IN ITALY: UPDATES ON THE PROCEDURE AS PER LAW 648/96
In Italy, law 648/96 allows NHS funding for the use of unauthorized medicinal products or for off-label indications of authorized…
READ
MEDICAL DEVICES – THE ITALIAN MOH MEDICAL DEVICE DATABASE WITH THE MDR ENTRY INTO FORCE
The Regulation EU 2017/745 (MDR) will enter into force in one month and with it the European database EUDAMED will…
READ
BREXIT: HOW DOES THIS PHENOMENON AFFECT MARKETING AUTHORIZATIONS IN ITALY?
It is now well-known that, following the Withdrawal Agreement between the United Kingdom and the European Union, the United Kingdom…
READ
DRUG DEVELOPMENT OPTIMIZATION USING MODELLING METHODOLOGY
Modeling and simulation are a proven scientific approach used to inform crucial drug development decisions. Specifically, scientists from the FDA…
READ
MARKET ACCESS – NEW GUIDELINES ON PRICING AND REIMBURSEMENT DOSSIERS OF MEDICINAL PRODUCTS
With Resolution no. 1372/2020, published on its institutional website on 30/12/2020, AIFA has adopted the consolidated version of the new…
READ
MEDICAL DEVICES – UK MEDICAL DEVICE REGULATION 2002 – HOW TO PLACE MEDICAL DEVICES IN THE UK MARKET AFTER THE BREXIT GRACE PERIOD END
No deal-Brexit grace period end is now upon us and starting from 1st January 2021 all the manufacturers wishing to…
READ
GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 PANDEMIC
The impact of the COVID-19 pandemic on health systems and more broadly on society, make it necessary for sponsors to…
READ